Liver function failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Gender unrestricted, aged 18 to 65; 2.Voluntary participation, informed consent; 3.Patients receiving tacrolimus treatment.
Exclusion criteria
Exclusion criteria: Difficult-to-follow-up individuals; Refusal to sign the informed consent form; Patients who experience severe complications after transplantation, with impaired liver or kidney function, and are at immediate risk of life-threatening conditions; Patients with concurrent heart disease, kidney disease, or other malignancies, which may interfere with prognosis or affect research outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentration of Tacrolimus;Fluorescence intensity;Reaction time;Sensitivity;Selectivity;Practicality;Accuracy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Height of the PC microarray;Reflection spectrum of the PC microarray; | — |
Countries
China
Contacts
3rd Medical Center of the Chinese PLA General Hospital